Sunovion gets FDA approval for Lonhala Magnair COPD treatment

The Sunovion Pharmaceuticals Inc. subsidiary of Sumitomo Dainippon Pharma Co. Ltd. (Tokyo:4506) said FDA approved

Read the full 150 word article

User Sign In